Cargando…
Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease?
Bladder cancer (BC) is a frequent type of carcinoma with an estimated incidence of approximately 100,000 men and women each year in the European Union (EU) with an associated mortality of 30,000 of these patients. In more than 70% the disease is diagnosed in a non-muscle invasive stage with the chan...
Autores principales: | Klaile, Yvonne, Schlack, Katrin, Boegemann, Martin, Steinestel, Julie, Schrader, Andres Jan, Krabbe, Laura-Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071184/ https://www.ncbi.nlm.nih.gov/pubmed/27785426 http://dx.doi.org/10.21037/tau.2016.06.13 |
Ejemplares similares
-
A prognostic score for overall survival in patients treated with abiraterone in the pre- and post-chemotherapy setting
por: Boegemann, Martin, et al.
Publicado: (2019) -
Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate
por: Boegemann, Martin, et al.
Publicado: (2016) -
The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone
por: Boegemann, Martin, et al.
Publicado: (2017) -
Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer
por: Schlack, Katrin, et al.
Publicado: (2016) -
Histological variants in non-muscle invasive bladder cancer
por: Baumeister, Philipp, et al.
Publicado: (2019)